<p>The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells. The invention further relates to a vaccine composition which comprises a VDV2 strain.</p>
申请公布号
CA2611954(C)
申请公布日期
2014.01.28
申请号
CA20062611954
申请日期
2006.06.07
申请人
SANOFI PASTEUR;CENTERS FOR DISEASE CONTROL AND PREVENTION
发明人
KINNEY, RICHARD;HUANG, CLAIRE;BARBAN, VERONIQUE;LANG, JEAN;GUY, BRUNO